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Meiotic errors followed by two parallel
postzygotic trisomy rescue events are a frequent
cause of constitutional segmental mosaicism
Caroline Robberecht1, Thierry Voet1, Gülen E Utine1,2, Albert Schinzel3, Nicole de Leeuw4, Jean-Pierre Fryns1 and
Joris Vermeesch1*
Abstract
Structural copy number variation (CNV) is a frequent cause of human variation and disease. Evidence is mounting
that somatic acquired CNVs are prevalent, with mosaicisms of large segmental CNVs in blood found in up to one
percent of both the healthy and patient populations. It is generally accepted that such constitutional mosaicisms
are derived from postzygotic somatic mutations. However, few studies have tested this assumption. Here we
determined the origin of CNVs which coexist with a normal cell line in nine individuals. We show that in 2/9 the
CNV originated during meiosis. The existence of two cell lines with 46 chromosomes thus resulted from two
parallel trisomy rescue events during postzygotic mitoses.
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Background
For decades, knowledge about copy number variation
(CNV) in the human genome was limited to microscopi-
cally visible changes. Advances in technology have led to
the discovery of submicroscopic CNVs, ranging from
kilobases to megabases in size and covering up to 13%
of the human genome [1,2]. These CNVs can cause
recurrent genomic disorders and sporadic disease, or
they can represent benign changes found in the healthy
population [3,4]. Recent studies have revealed that
CNVs are not only polymorphic between unrelated indi-
viduals, but also form a frequent source of somatic var-
iation [5,6].
Chromosomal mosaicism is defined as the coexistence
of two or more chromosomally different cell lines in an
organism which developed from a single zygote. The
majority of those mosaicisms are aneuploidies. Several
studies investigating in vitro fertilized embryos at the
preimplantation stage demonstrated a very high number
of chromosomal mosaicisms in early human embryos
[7-9]. While many of these embryos will not reach the
stage of implantation, some do continue to develop
leading to fetal mosaicisms, confined placental mosai-
cism or mosaic infants. Postnatally, mosaicism is
detected in 0.4-1% of patients referred for genetic diag-
nostic screening [10-12]. A recent study revealed that
mosaic aberrations are present in about 0.8% of pheno-
typically normal adults [13]. In addition, mosaicism
appears to be variable amongst different tissues: chro-
mosomal aneuploidies were detected in approximately
10% of normal human brain cells [14].
Segmental aneuploidies make up a significant part of
mosaic chromosome anomalies. Analysis of several large
series of prenatal samples by karyotyping has shown
that, of the 0.25-2% mosaic cases that are detected, up
to a third comprise segmental imbalances [15,16]. In
postnatal clinical diagnosis of patients with developmen-
tal anomalies this increases to about half of the mosaic
cases [10,17]. The majority of mosaic segmental imbal-
ances are marker chromosomes [16]. A smaller number
of cases have been reported to consist of mosaic seg-
mental deletions and/or duplications, ring chromosomes
and translocations that have a 46,abnormal/46,normal
karyotype. In recent years various case reports have
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been published [18-36]. The introduction of genome
wide aneuploidy detection tools with a higher resolution
such as array comparative genomic hybridisation (array
CGH) or SNP arrays and the collection of large patient
groups have also increased the detection rate of mosaic
segmental abnormalities [10,12,17].
For mosaic aberrations, it is intuitively assumed that
the rearrangement arose postzygotically. During embry-
ogenesis, a mitotic rearrangement in an otherwise nor-
mal diploid embryo results in a second cell line carrying
a chromosomal rearrangement. Nevertheless, evidence is
mounting that such rearrangements can originate during
meiosis. If so, a trisomic zygote carrying the abnormal
chromosome has to be rescued twice, in parallel: once
loosing the normal and once loosing the abnormal chro-
mosome. Considering that the mitotic error rate is
extremely high during early embryogenesis [7-9] and
that most cases of mosaic aneuploidy detected in a large
cohort of patients were of mitotic origin [11], we rea-
soned that the latter mechanism might be an important
mechanism by which such mosaics arise. In this study
we collected nine cases with mosaic structural imbal-
ances to determine their origin and to ascertain whether
a meiotic or postzygotic origin might be more prevalent.
Results
All nine samples contained two different cell lines, each
with 46 chromosomes: one normal diploid cell line and
a second cell line carrying a chromosomal rearrange-
ment. In five cases the mosaicism was detected in blood
lymphocytes, in three cases (case 4, 8 and 9) in amnio-
cytes and in one case (case 6) in chorionic villi. In addi-
tion to the mosaicism present in the white blood cells,
the mosaicism was confirmed in buccal cells in cases 7
and 9. Conventional karyotyping was carried out in five
cases and detected the mosaicism in four out of five.
Microarrays were performed on DNA from 8/9 cases to
identify or confirm the segmental aneuploidy, determine
its size and rule out any additional chromosomal imbal-
ances (Figures 1 and 2). The array intensity ratios indi-
cated duplications in approximately 66, 55, 53, 72 and
15% of the cells in patients 1, 2, 3, 4 and 5 respectively.
Figure 1 Microarray profiles of the affected chromosome in cases 1, 2, 3, 4 and 5. The dots on the X-axis represent the BAC clones
ordered from the short-arm telomere to the long-arm telomere. The Y-axis shows log2 transformed intensity ratios of the combined dye-swap
BAC array experiments (case Cy5/control Cy3). The grey bar indicates the theoretical log2 ratio of a non-mosaic duplication, while the thick black
bars indicate the individual mosaicism level per case.
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The array intensity ratios indicated the presence of seg-
mental deletions in approximately 20 and 30% of the
cells in samples 8 and 9. In two samples, 6 and 7, both
deletions and duplications were identified by karyotyp-
ing (case 6) or array CGH (case 7) in respectively 50
and 20% of the cells. Conventional karyotyping showed
those imbalances to be unbalanced translocations. FISH
confirmed the mosaic segmental imbalances in six sam-
ples. FISH also determined that the duplication in cases
1 and 4 was not translocated to another chromosome
and that cases 5 and 7 carry unbalanced translocations.
The karyotypes are presented in Table 1. The degree of
mosaicism was estimated based on the intensity ratios
of the targets located within the segmental aneuploidy
or on data from FISH analysis. The segment sizes and
estimated relative presence of the segmental aneuploidy
range between 1 and 124 Mb and an overview is shown
in Table 1. Chromosome analysis of the parents, includ-
ing FISH for submicroscopic aberrations, was normal
for all.
To determine whether the initial rearrangement
occurred during meiosis or during postzygotic mitosis,
polymorphic marker analysis or SNP array analysis was
performed. For patients 1 to 6, carrying segmental
duplications, markers were selected within and flanking
the duplicated region. If the duplication arose during
meiosis, three alleles might be observed. If only two
alleles are detected, there are two possible explanations:
either the duplication arose postzygotically or the dupli-
cation arose during meiosis and the segmental
Figure 2 Microarray profiles of the affected chromosome in cases 7, 8 and 9. The plots of the aberrant chromosomes obtained with 250 k
SNP array analysis are shown with test over reference log2 intensity ratios on the Y-axis plotted against the Mb position from pter to qter on
the X-axis. Each red dot represents the test over reference ratio for an individual SNP and the blue line the average test over reference ratio per
10 SNP values.
Table 1 Combined karyotypes after conventional and molecular cytogenetic analyses
case Karyotype (ISCN 2009; Mb positions mapped in hg19) %
mos
del/dup size
1 46,XX,dup(13)(q31.3q33.1)dn/46,XX.arr 13q31.3q33.1 (RP11-319 L6-RP11-564 N10)x2 ~3 66% 11.11 Mb
2 46,XX,dup(15)(q25q26.3)dn/46,XX.arr 15q25.2q26.3 (RP11-365 F16-CTB-154P1)2 ~3 55% 18.25 Mb
3 46,XY,dup(11)(q12.1q13.3)dn/46,XY.arr 11q12.1q13.3 (RP11-131 J4-RP11-804 L21)2 ~3 53% 14.55 Mb
4 46,XY,dup(1)(q12q32.1)dn/46,XY.arr 1q12q32.1 (RP11-417 J8-RP11-383 G10)2 ~3 72% 62.72 Mb
5 46,XX,der(6)t(2;6)(p23.2;qter)dn/46,XX.arr 2p25.3p23.2 (GS1-68 F18-RP11-328 L16)2 ~3 15% 29.36 Mb
6 46,XY,der(20)t(1;20)(10q;10p)dn/46,XY * 50% 25.56 Mb/124.2
Mb
7 46,XX,der(10)t(9;10)(p23;q26.13)dn/46,XX.arr 9p24.3p23(40,910-13,575,891)x2 ~3, 10q26.13q26.3 (124,007,108-
135,422,505)x1 ~2
20% 13.53 Mb/11.31
Mb
8 46,XX.ish del(11)(q14.1q14.2)(RP11-118 L16-,RP11-157B22-)dn[21/50].arr 11q14.1q14.2(83,122,844-86,794,856)x1 ~2 20% 3.7 Mb
9 46,XX.ish del(1)(q43q44)(RP11-113O11-,RP11-370 K11-)dn[25/50].arr 1q43q44(242,916,876-243,920,382)x1 ~2 30% ~1 Mb
*Insufficient DNA for array analysis
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duplication is one of both sister chromatids present dur-
ing meiosis I or II. Results of the short tandem repeat
(STR) analyses are shown in Figures 3, 4 and 5 and a
summary is presented in Table 2.
For two samples, three different alleles were detected
within the duplicated region indicating a meiotic origin.
Polymorphic marker analysis of sample 1 revealed the
presence of three different alleles for marker D13S128
(Figure 3A). Two of the alleles were inherited from the
father demonstrating the paternal origin of the segmen-
tal aneusomy. At marker D13S129, still within the dupli-
cation, two alleles with a 2:1 intensity ratio were
detected, including only one of the two paternal alleles
(Figure 3B). The remaining markers within the duplica-
tion were not informative. In case 6, carrier of an unba-
lanced translocation, two markers (D1S1653 and
D1S1171) spread throughout the duplicated 1q region
showed three different alleles (Figure 4). The other mar-
kers on 1q had either one or two alleles. Marker
D20S117 in the deleted 20p region confirmed the dele-
tion, with a 1:2 reduced peak intensity for one of both
alleles.
For the other cases, only two different alleles were
identified within the duplication region. Genotyping of
cases 2 to 5 within the region of duplication showed in
each case only two alleles. One of both alleles clearly
had a higher intensity with about a 2:1 ratio (Figure 5).
For sample 5, in which array CGH revealed that the
rearrangement is only present in 10 to 20% (log2 value
of 0.0888) of all cells, these peak intensity differences
were still present, but to a lesser extent.
For patients 7 to 9 with mosaic segmental deletions,
single nucleotide polymorphisms were analyzed by 250
K Affymetrix SNP arrays. To determine the origin of
the mosaic unbalanced translocation in case 7, geno-
typed by Affymetrix SNP arrays, the following strategy
was followed: the A and B allele ratios of individual
SNPs within the segmental mosaic duplication and dele-
tion were determined for those SNPs that were homozy-
gous but with a different allele in both parents. Analysis
of the A and B allele ratios transmitted from parental
homozygous AA and BB SNPs showed 77 SNPs to fulfill
this criteria in the duplication and 51 SNPs in the dele-
tion and demonstrated a paternal origin for both the
deleted and the duplicated segments of the unbalanced
translocation. Subsequently, the A and B allele ratios of
SNPs in the duplicated region that were paternal hetero-
zygous but maternal homozygous were interrogated.
Analysis of the SNPs did not show transmission of both
paternal alleles. Only a single duplicated allele from the
father was detected (Figure 6A).
To determine the origin of the deletion in cases 8 and
9, again for the SNPs that were homozygous but with a
different allele in both parents in the deletion, the A
and B allele ratios were determined. The analysis
showed that the signal of the paternal allele was reduced
in case 8 and that a maternal allele was removed in case
9. To search for evidence of a potential meiotic event,
Figure 3 Short tandem repeat analysis on DNA of the patient and parents. A) Case 1 has three different alleles for marker D13S128
corresponding to two different paternal alleles and one maternal allele. B) At marker D13S129 case 1 has two identical paternal alleles and one
maternal allele. This indicates the paternal origin of the duplication in chromosome 13 and suggests a cross-over occurred between the paternal
chromosomes 13 followed by a meiosis II non-disjunction and an unequal sisterchromatid exchange. C: case, F: father, M: mother.
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the rest of the chromosome was screened for the pre-
sence of two paternal (case 8) or two maternal alleles
(case 9). Hereto, the B-allele frequencies of SNPs on the
affected chromosome, but outside the somatic CNV
region, were evaluated for additional haplotypes. If the
deletion resulted from a meiotic event, altered B-allele
frequencies would be observed, with additional values
between 0 and 0.5 as well as between 0.5 and 1. No
such haplotypes were detected in the regions surround-
ing the deletion (Figure 6B).
The combination of a normal and an aberrant cell line
in these cases could, aside from mosaicism, also result
from chimerism: the fusion of two cell lineages from
separate fertilization events. In samples 1 to 6, the pre-
sence of chimerism was evaluated by testing four STR
markers spread over different chromosomes not
involved in the aberrant region. in case of a mosaic all
autosomal genotypes outside the duplicated region are
expected to only contain two alleles (1 maternal & 1
paternal). For chimeras, some loci would have three or
four alleles, or a skewed dosage of two alleles [37].
None of the samples showed more than two alleles on
any of the markers, confirming the mosaic status of the
aberration (data not shown). In cases 7 to 9, the two dif-
ferent genotypes present in case of chimerism would be
seen as aberrant B-allele frequencies in all autosomes,
with an altered ratio between the two haplotypes. No
alterations in the B-allele frequency were seen in the
unaffected chromosomes, thereby ruling out the possibi-
lity of chimerism.
Figure 4 Short tandem repeat analysis on fetal DNA of case 6.
Case 6 shows two alleles with a 2:1 ratio for marker D1S1595 (A)
and three different alleles for markers D1S1653 (B) and D1S1171 (C).
This suggests a meiosis I origin for the duplicated segment of the
unbalanced translocation.
Figure 5 Short tandem repeat analysis on DNA of cases 2, 4 and 5 and parental DNA. A) Case 2 has a difference in peak ratios in marker
D15S130 corresponding to two identical paternal alleles and one maternal allele. B) Case 4 demonstrates a 2:1 peak ratio in marker D1S2635
corresponding to two identical paternal alleles and one maternal allele. C) Case 5 shows a duplication of the maternal allele in marker D2S1780.
C: case, F: father, M: mother.
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Discussion
Somatic chromosomal mosaicisms are thought to arise
from postzygotic somatic mutations. Here, we show that
in two out of nine cases (>15%) the rearrangements
occurred preconception. Cases 1 and 6 showed markers
with three different alleles in the duplicated region. The
most parsimonious explanation is that both aberrations
originated from a meiotic segregation error resulting in a
trisomic conception, followed by two parallel trisomy res-
cue events during the successive mitotic divisions (Figure
7). In the other seven cases (pt 2-5 & pt 7-9), the duplica-
tion was derived from the chromosome with the same par-
ental allele as the transmitted chromosome in the normal
cell line or the deletion was on the chromosome with the
same parental allele as the normal chromosome in the
normal cell line. In these cases the copy variation likely
occurred during postzygotic cell divisions. Nevertheless,
those rearrangements could also have occurred during
meiosis II. Hence, the percentage of mosaic segmental
imbalances generated during meiosis by two separate post-
zygotic trisomy rescue events could be higher than 15%.
The occurrence of multiple postzygotic trisomy rescue
events may appear to be unexpected. However, a high fre-
quency of mosaic trisomies and monosomies is reported
to occur during cleavage stage in in vitro fertilized
embryos [7-9]. The observation that two independent tris-
omy rescue events can underlie those mosaicisms is
further testimony of this high mutational burden during
early embryogenesis. Postzygotic trisomy rescue events are
also frequently observed in patients with imprinting dis-
eases, including Prader-Willi syndrome and Silver-Russell
syndrome. Such patients may be fully disomic with com-
plete uniparental disomy (UPD) or be mosaic with a triso-
mic and a disomic (UPD) cell line [11,38-40].
While the origin of mosaic segmental CNVs has only
rarely been investigated, two case reports support our
finding that pre-zygotic rearrangements followed by
multiple postzygotic trisomy rescue events can underlie
segmental mosaicisms. Blouin et al. detected a mosaic
de novo direct tandem duplication of 21q11.2q22.2 that
resulted from a meiosis I crossover followed by an
unequal sister chromatid exchange and two trisomy res-
cue events, similar to our case 1. The mosaic de novo
unbalanced translocation with partial trisomy 16p and
maternal UPD 16 reported by Schinzel et al. likely origi-
nated from a maternal trisomy 16 (MI), a subsequent
postzygotic translocation of the paternal 16p segment
and finally loss of the paternal chromosomes 16 in the
translocated and normal cell lines [18,32]. Even after
combining our results with previous mosaic segmental
cases the total study population remains small, but
Table 2 Results of the STR marker analysis
case 1 marker location F/C/M
D13S232 13q12.12 ac/ac/ab
D13S129 13q31.3 ac/aab/bc
D13S128 13q32.2 ac/acd/bd
D13S770 13q32.3 ab/aab/ab
D13S779 13q32.3 ab/aab/ac
D13S1315 13q34 ac/bc/ab
D13S285 13q34 b/bc/ac
case 2 marker location F/C/M
D15S165 15q13.2-q13.3 ab/ab/ac
D15S222 15q21.1 ab/ab/ab
D15S116 15q26.1 bc/bbc/ac
D15S127 15q26.1 cd/bdd/ab
D15S158 15q26.1 ac/bcc/ab
D15S130 15q26.2 bd/bbc/ac
case 3 marker Location F/C/M
D11S1357 11q12.1 b/b/ab
D11S480 11q12.3 bd/bbc/ac
D11S913 11q13.1-q13.2 ?/aac/bc
D11S4095 11q13.3 bc/abb/ad
D11S1314 11q13.4 ?/bc/ab
D11S916 11q13.4 ?/a/a
D11S1339 11q22.1-q22.2 ?/ab/ac
D11S4111 11q23.3 ?/bc/ab
case 4 marker location F/C/M
D1S1595 1q22 ac/c/bc
D1S1653 1q23.1 ?/b/ab
D1S2635 1q23.2 cd/acc/ab
D1S2705 1q23.3 ac/aab/b
D1S212 1q25.2 ac/bcc/bd
D1S1171 1q32.1 ?/a/ab
D1S2631 1q42.13 a/ab/ab
case 5 marker location F/C/M
D2S2268 2p25.3 b/b/ab
D2S2245 2p25.3 ac/bbc/bc
D2S319 2p25.3 ab/bcc/bc
D2S1780 2p25.3 ac/aac/ab
case 6 marker location
D1S1595 1q22 aab
D1S1653 1q23.1 abc
D1S2635 1q23.2 ab
D1S2705 1q23.3 a
D1S212 1q25.2 ab
D1S1171 1q32.1 abc
case 6 marker location
D20S117 20p13 ab
Results of the STR marker analysis. Highlighted markers lie within the
duplicated or deleted regions. Informative marker results are underlined and
highlighted. F: father, C: case, M: mother.
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future studies may be able to provide additional evi-
dence for the high frequency of multiple independent
trisomy rescue events.
Conclusions
In conclusion, we demonstrated that in 2/9 cases, the
detected mosaic segmental aberrations resulted from
meiotic errors followed by multiple parallel trisomy res-
cue events and not from postzygotic mitotic changes. In
addition, we show that the use of sensitive array tech-
nology is especially suited for the detection of mosai-
cism, which is clinically relevant to a patient’s diagnosis.
Methods
Patient selection
Five cases were referred for cytogenetic/molecular inves-
tigations after clinical evaluation for dysmorphic
features, whereas cases 4, 6, 8 and 9 were ascertained
during prenatal diagnosis (CVS and/or amniocentesis).
Cytogenetic Analysis
Cytogenetic analyses were performed on GTG-banded
metaphase chromosomes from PHA-stimulated periph-
eral blood lymphocytes or from CVS cells or amniocytes
after standard culture and chromosome preparation pro-
tocols. Twenty metaphases with a resolution of 550
bands per haploid genome were karyotyped (ISCN 2009).
BAC microarray analysis was performed as described
elsewhere [41]. Briefly, CodeLink Bioarray System slides
(Amersham Biosciences, Chalfont St.Giles, UK) were used
for array construction using a 1 Mb clone set of 3 683
BAC and PAC clones. Genomic DNA from the index
patient and two other patients was labelled in Cy3 and
Cy5, respectively (Amersham Biosciences, Chalfont St.
Figure 6 SNP array analysis of cases 7 and 8. A) SNP cluster plots of individual SNPs. Green, red and black dots represent controls with a BB,
AB and AA genotype respectively. The pink and blue dots represent the genotypes of the mother and father. The yellow dots indicate the
genotype of case 7 in cells with the duplication, while the orange dots give the genotype of the normal cells of the fetus. The SNPs shown are
located within the paternal duplication. The plots indicate that paternal heterozygous SNPs in the duplicated region do not show transmission
of both paternal alleles, but instead revealed a duplication of one of the paternal alleles. This suggests the duplication originated during
postzygotic mitosis or meiosis II. B) The B allele frequency graph of chromosome 11 shows abnormal heterozygous values without complete loss
of heterozygosity in the deleted segment in case 8. No additional haplotypes are found in the regions surrounding the deletion. This rules out
the possibility of a trisomy rescue and indicates the deletion originated during postzygotic mitosis or meiosis II.
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Giles, UK) with random prime labelling (Bioprime array
CGH, Invitrogen, Sunnydale, CA) and hybridized in a 3-
way experiment. Hybridization and post-hybridization
washing steps were performed as previously described
[41]. Slides were scanned at 532 nm (Cy3) and 635 nm
(Cy5) using a GenePix 4000B microarray scanner (Axon
Instruments, Union City, CA) with the software GenePix-
Pro 6.0. Data analysis was performed with Excel (Micro-
soft Inc.; Diegem, Belgium) as described [41]. The
percentage of mosaicism was calculated by dividing the
mean log2 ratio of the BAC clones in the duplicated
region by the log2 of a non-mosaic aberration (0.5849).
SNP array analysis was performed on Affymetrix Gen-
eChip® Human Mapping 250 K NspI arrays (Affymetrix,
Inc., Santa Clara CA, USA) containing 25-mer oligonu-
cleotides representing a total of 262 264 SNPs. DNA
digestion, labeling and hybridization were performed
according to the manufacturer’s protocol. After hybridi-
zation, arrays were washed and stained on the Affyme-
trix GeneChip fluidics station 450 and scanned using
the Affymetrix GeneChip® Scanner 3000 7 G. Data ana-
lysis was performed using Copy Number Analyzer for
GeneChip version 2.0 (CNAG 2.0) [42] and Genotyping
Console™ Software (Affymetrix, Inc.).
Fluorescent in situ hybridization
To confirm aberrations found by microarray, FISH was
performed with BAC probes as described [43], using an
optical fluorescence microscope (Olympus U-SPT, BX51,
Japan) with selective filters equipped with CytoVision®
software (Applied Imaging, Genetix, Gateshead, UK).
SNP cluster determination
For determining the parental origin of the DNA copy
number aberrations by a SNP-cluster strategy, normal-
ized SNP A and B allele intensities as well as SNP geno-
type calls were computed using Affymetrix power tools
(APT-1.10.1) in combination with the Birdseed com-
mand [44]. Besides the described trio datasets, in-house
produced Affymetrix 250 K SNP NspI data from 102
additional DNA samples were co-processed for accurate
SNP cluster and genotype determination. Subsequently,
the probe intensities and genotype calls for SNPs within
the regions of interest were retrieved for all DNA sam-
ples and interpreted by custom R-code [45] in which
patient and parental SNP-probe intensities are visualised
in the Birdseed SNP clusters from the 102 individuals.
B-allele frequency plots
To generate the B-allele frequency (BAF) plots, copy
number analysis of the SNP array data was performed
using the Affymetrix power tools BRLMM, a modified
version of RLMM [46] and the pennCNV [47] algo-
rithm. These data were subsequently further interpreted
and visualized in BAF and logR ratio plots by the gen-
oCN algorithm [48].
Figure 7 Schematic representation of the events leading to the mosaicism in cases 1 and 6. A) In case 1, there was likely a recombination
between the two paternal homologous chromosomes 13, followed by a duplication of part of the recombined chromosome. A subsequent non-
disjunction resulted in a trisomic zygote, that lead to a normal and an abnormal cell line through two trisomy rescue events. B) The mosaicism
in case 6 presumably originated from a translocation between chromosome 1 and chromosome 20 during meiosis I, with segregation of a
normal and a derivative chromosome 20 to the zygote. This results in a zygote which is trisomic for chromosome 20p and 1q and could lead to
the mosaicism seen in this case by trisomy rescue of the derivative chromosome (normal cells) and trisomy rescue of a normal chromosome 20
(abnormal cells).
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Polymorphic microsatellite marker analysis
Polymorphic microsatellite markers made up of dinu-
cleotide (CA)n repeats (short tandem repeats or STRs)
were selected from the Ensembl [49] and UCSC [50]
genome browser databases and the oligonucleotides
were purchased from Eurogentec S.A. (Seraing, Belgium)
and Pharmacia Biotech (Uppsala, Sweden). Genomic
DNA was extracted from peripheral blood leukocytes,
amniocytes or CVS cells of the patients and their par-
ents according to standard procedures and CA repeats
spaced along the involved chromosomes were amplified
by polymerase chain reaction (PCR). DNA extracted
from skin fibroblasts was also included in the analysis in
case the mosaicism was encountered in fibroblasts.
After PCR amplification of the STRs, fragments were
analyzed by gel electrophoresis. Automated fragment
sizing was performed on the ABI Prism 3100 Genetic
Analyzer (Applied Biosystems, Nieuwerkerk a/d Ijssel,
the Netherlands), using software GeneScan or Gene-
mapper v4.0 (Applied Biosystems, Nieuwerkerk a/d Ijs-
sel, The Netherlands).
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